Safety and Efficacy of Intravitreal Triamcinolone Acetonide for Uveitic Macular Edema

By Androudi Sofia   Letko Erik   Meniconi Margherita   Papadaki Thekla   Ahmed Muna   Foster C.  

Ocular Immunology and Inflammation, Vol. 13, Iss. 2-3, 2005-04 ,pp. : 205-212

Informa Healthcare

Access to resources Recommend Favorite

Short-term Results of a Single Intravitreal Bevacizumab (Avastin) Injection versus a Single Intravitreal Triamcinolone Acetonide (Kenacort) Injection for the Management of Refractory Noninfectious Uveitic Cystoid Macular Edema

By Lasave Andrés F.   Zeballos David G.   El-Haig Wael M.   Díaz-Llopis Manuel   Salom David   Arevalo J. Fernando  

Ocular Immunology and Inflammation, Vol. 17, Iss. 6, 2009-12 ,pp. : 423-430

Informa Healthcare

Access to resources Recommend Favorite

A Pilot Study of Intravitreal Diclofenac versus Intravitreal Triamcinolone for Uveitic Cystoid Macular Edema

By Soheilian Masoud   Eskandari Armen   Ramezani Alireza   Rabbanikhah Zahra   Soheilian Roham  

Ocular Immunology and Inflammation, Vol. 21, Iss. 2, 2013-04 ,pp. : 124-129

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization

By Doctor Priyanka   Bhat Pooja   Sayed Reema   Foster C. Stephen  

Ocular Immunology and Inflammation, Vol. 17, Iss. 2, 2009-04 ,pp. : 118-126

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal Bevacizumab (Avastin) for the Treatment of Cystoid Macular Edema in Behcet Disease

By Mirshahi Ahmad   Namavari Abed   Djalilian Ali   Moharamzad Yashar   Chams Hormoz  

Ocular Immunology and Inflammation, Vol. 17, Iss. 1, 2009-02 ,pp. : 59-64

Informa Healthcare

Access to resources Recommend Favorite